WORLD JOURNAL OF PLASTIC SURGERY
Mon, Dec 11, 2023
[Archive]
Mehryar Nahaei1 
, Gholamreza Motazedian2 , Ali-Akbar Mohammadi2 , Mohammad Ali Davarpanah3 , Parsa Yazdanpanahi4 , , Nazanin Ayareh , Fateme Salari5 , Alireza Keshtkar4
, Gholamreza Motazedian2 , Ali-Akbar Mohammadi2 , Mohammad Ali Davarpanah3 , Parsa Yazdanpanahi4 , , Nazanin Ayareh , Fateme Salari5 , Alireza Keshtkar4
1- 1. Department of Plastic and Reconstructive Surgery, Shiraz University of Medical Sciences, Shiraz, Iran
2- 2. Burn and Wound Healing Research Centre, Plastic and Reconstructive Surgery Ward, Shiraz University of Medical Sciences, Shiraz, Iran
3- 3. Infectious Disease Department, Shiraz University of Medical Sciences, Shiraz, Iran
4- 4. Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
5- 5. Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
2- 2. Burn and Wound Healing Research Centre, Plastic and Reconstructive Surgery Ward, Shiraz University of Medical Sciences, Shiraz, Iran
3- 3. Infectious Disease Department, Shiraz University of Medical Sciences, Shiraz, Iran
4- 4. Student Research Committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
5- 5. Trauma Research Center, Shahid Rajaee (Emtiaz) Trauma Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract: (124 Views)
Background: COVID-19, caused by SARS-CoV-2, is a global pandemic that particularly affects immunocompromised individuals, leading to secondary bacterial and fungal infections. Mucormycosis, caused by Mucorales fungi, is a severe infection primarily affecting immunocompromised individuals. The COVID-19 pandemic has seen a surge in mucormycosis cases worldwide, with India experiencing a significant increase. Various factors, including diabetes mellitus, contribute to the risk of mucormycosis. This study investigated head and neck mucormycosis in patients with prior COVID-19 infection.
Methods: Data from 45 patients were analyzed, with diabetes being the most common risk factor. Visual symptoms, ethmoid bone involvement, and orbital bone involvement were also identified as significant factors.
Results: The COVID-19 pandemic has led to an increase in mucormycosis cases, particularly in the head and neck region, with high mortality. Successful management involves addressing underlying factors, surgical debridement, and antifungal therapy.
Conclusion: Timely debridement reduces morbidity and mortality.
Methods: Data from 45 patients were analyzed, with diabetes being the most common risk factor. Visual symptoms, ethmoid bone involvement, and orbital bone involvement were also identified as significant factors.
Results: The COVID-19 pandemic has led to an increase in mucormycosis cases, particularly in the head and neck region, with high mortality. Successful management involves addressing underlying factors, surgical debridement, and antifungal therapy.
Conclusion: Timely debridement reduces morbidity and mortality.
Type of Study: Original Article |
Subject:
Special
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
